Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.

Lanjun Wang, Mengqi Li, Rong LianPubMed 2022 · DOI

Abstract

The hsa_circ_0000567/miR-377-3p/ZFX axis might contribute to acquired gefitinib resistance in LUAD cells both in vitro and in vivo, suggesting hsa_circ_0000567 as a novel therapeutic target in treatment of gefitinib-resistant LUAD.
BibTeX
@inproceedings{wang2022depleting,
  author = {Lanjun Wang and Mengqi Li and Rong Lian},
  title = {{Depleting hsa\_circ\_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.}},
  booktitle = {PubMed},
  year = {2022},
  doi = {10.14670/hh-18-431},
}

Loading related content...

Figure